Blog
RSS FeedPosted by Michael Wonder on 16 Nov 2019
PBAC Public Summary Documents - July 2019 meeting
15 November 2019 - The Public Summary Documents (first time rejections and deferrals) from the July 2019 PBAC meeting are now ...
Posted by Michael Wonder on 16 Nov 2019
Novartis receives positive CHMP opinion for Mayzent (siponimod) for the treatment of adult patients with active secondary progressive multiple sclerosis
15 November 2019 - If approved, Mayzent (siponimod) will be the first and only oral treatment specifically indicated for patients ...
Posted by Michael Wonder on 15 Nov 2019
Highlights from the CHMP 11-14 November 2019 meeting
15 November 2019 - Seven new medicines recommended for approval. ...
Posted by Michael Wonder on 14 Nov 2019
Health products portal – intent to apply
14 November 2019 - The Department of Health (the Department) has been working to digitise and simplify the PBS submission ...
Posted by Michael Wonder on 13 Nov 2019
ICER seeks public input to guide selection of non-drug assessment topics for 2020
13 December 2019 - Suggestions for new topics and comments on initial list of potential topics are encouraged; input most helpful ...
Posted by Michael Wonder on 13 Nov 2019
NICE recommends Elmiron for bladder pain syndrome
13 November 2019 - NICE has recommended Consilient Health’s Elmiron (pentosan polysulfate sodium) for bladder pain syndrome. ...
Posted by Michael Wonder on 13 Nov 2019
NICE during the pre-election period
12 November 2019 - As a public body, NICE is required to follow civil service principles on communicating during the lead ...
Posted by Michael Wonder on 13 Nov 2019
ICER finalises method adaptations for assessing potential cures and other high-impact single or short-term therapies
12 November 2019 - Collaborative project with NICE and CADTH leads to important adaptations for ICER’s methods including creation of optimistic ...
Posted by Michael Wonder on 12 Nov 2019
Health economic assessment of Tecentriq for triple negative breast cancer
8 November 2019 - TLV has produced a health economic knowledge base for the county council for the drug Tecentriq (atezolizumab). ...
Posted by Michael Wonder on 12 Nov 2019
EMA publishes agenda for 11-14 November CHMP meeting
11 November 2019 - The EMA has published a draft agenda for this week's CHMP meeting. ...
Posted by Michael Wonder on 11 Nov 2019
Breast and kidney cancer drugs get approval for use across Scotland's NHS
11 November 2019 - Medicines for breast and kidney cancers are among five new drugs which can now be used ...
Posted by Michael Wonder on 11 Nov 2019
SMC - November 2019 decisions
11 November 2019 - A medicine used to treat advanced breast cancer has today been accepted by the SMC for ...
Posted by Michael Wonder on 11 Nov 2019
NICE U-turn for Epidyolex in epilepsy
11 November 2019 - GW Pharma has announced that NICE has recommended Epidyolex (cannabidiol) for two rare, severe forms of ...
Posted by Michael Wonder on 07 Nov 2019
ICER releases draft evidence report on acute migraine therapies
7 November 2019 - Public comment period on preliminary draft now open until 6 December 2019; requests to make oral comment ...
Posted by Michael Wonder on 07 Nov 2019
PBS process improvements information forum
7 November 2019 - The Department of Health will be hosting a webinar on 21 November 2019. ...